Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly onset type 2 diabetics is moving into the...
/PRNewswire/ -- Immunovia today announced results from the PanFAM-1 study. The PanFAM-1 study is a prospective, multi-center, investigational study, designed...
/PRNewswire/ -- The Pennsylvania and Maryland Departments of Health have granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV),...
LUND, Sweden, May 23, 2022 /PRNewswire/ -- The Pennsylvania and Maryland Departments of Health have granted...
LUND, Sweden, May 17, 2022 /PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical Laboratory